Process and methods for the preparation of optically active cis2-Hydroxymethyl-4-(cytosin-1'-yl)-1,3-o xathiolane or pharmaceutically acceptable salts thereof

Details for Australian Patent Application No. 2005329355 (hide)

International Classifications

Event Publications

25 October 2007 PCT application entered the National Phase

PCT publication WO2006/096954 Priority application(s): WO2006/096954

10 January 2008 Amendment Made

The nature of the amendment is: Amend co-inventor names to read Simion, Dan and Cimpoia, Alex

10 January 2008 Alteration of Name

The name of the applicant has been altered to Shire Canada Inc. 2006

18 August 2011 Application Accepted

Published as AU-B-2005329355

8 September 2011 Application for Amendment

The nature of the amendment is: Amend the invention title to read Process and methods for the preparation of optically active cis2-Hydroxymethyl-4-(cytosine-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts . Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000

2 February 2012 Standard Patent Sealed

23 February 2012 Corrigenda

Applications Accepted - Name Index Under the name Shire Canada Inc., Application No. 2005329355, under INID (54) correct the title to read Process and methods for the preparation of optically active cis2-Hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.